The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade

Autoimmune blistering diseases of the skin

(2011) Michael Sticherling et al.   AUTOIMMUNITY REVIEWS

Dendritic cells modulate platelet activity in IVIg-mediated amelioration of ITP in mice

(2010) H.-S. Huang et al.   BLOOD

IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes

(2010) J.-F. Seite et al.   BLOOD

Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris

(2010) D. Mimouni et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Blocking of IL-6 suppresses experimental autoimmune myasthenia gravis

(2010) Revital Aricha et al.   JOURNAL OF AUTOIMMUNITY

A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs

(2010) Robert M. Anthony et al.   JOURNAL OF CLINICAL IMMUNOLOGY

Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view

(2010) PL Meroni et al.   LUPUS

Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis

(2009) Maria Giovanna Danieli et al.   AUTOIMMUNITY REVIEWS

Kawasaki disease: Aetiopathogenesis and therapeutic utility of intravenous immunoglobulin

(2009) Caroline Galeotti et al.   AUTOIMMUNITY REVIEWS

Using high titer West Nile intravenous immunoglobulin from selected Israeli donors for treatment of West Nile virus infection

(2009) David Ben-Nathan et al.   BMC INFECTIOUS DISEASES

An ‘n-of-1’ placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris

(2009) D.F. Arnold et al.   BRITISH JOURNAL OF DERMATOLOGY

Natural antibodies, intravenous immunoglobulin and their role in autoimmunity, cancer and inflammation

(2009) R. Schwartz-Albiez et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Evidence for the Use of Intravenous Immunoglobulins—A Review of the Literature

(2009) Shaye Kivity et al.   CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY

Anti-vascular endothelial growth factor (VEGF) specific activity of intravenous immunoglobulin (IVIg)

(2009) M. Damianovich et al.   INTERNATIONAL IMMUNOLOGY

A randomized double-blind trial of intravenous immunoglobulin for pemphigus

(2009) Masayuki Amagai et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Intravenous immunoglobulins in systemic lupus erythematosus: from the bench to the bedside

(2009) G Zandman-Goddard et al.   LUPUS

Treatment of Myasthenia Gravis Acute Exacerbations with Intravenous Immunoglobulin

(2008) Philippe Gajdos et al.   Annals of the New York Academy of Sciences

Anti-Inflammatory Actions of Intravenous Immunoglobulin

(2008) Falk Nimmerjahn et al.   Annual Review of Immunology

Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies

(2008) Philippe Guilpain et al.   AUTOIMMUNITY REVIEWS

What is the contents of the magic draft IVIg?

(2008) Jean-François Seite et al.   AUTOIMMUNITY REVIEWS

A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis

(2008) Sara Fuchs et al.   JOURNAL OF NEUROIMMUNOLOGY

Identification of a receptor required for the anti-inflammatory activity of IVIG

(2008) R. M. Anthony et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc

(2008) R. M. Anthony et al.   SCIENCE